COMPARISON OF PERFORMANCE OF ACR EULAR 2022 REMISSION CRITERIA IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM INDIA

被引:0
作者
Kumar, A. [1 ]
Gopalakrishnan, M. [1 ]
Garg, M. K. [1 ]
机构
[1] All India Inst Med Sci, Internal Med, Jodhpur, India
关键词
Remission; Disease-modifying drugs (DMARDs); Rheumatoid; arthritis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0208
引用
收藏
页码:1287 / 1288
页数:2
相关论文
共 3 条
  • [1] THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY CORE SET OF DISEASE-ACTIVITY MEASURES FOR RHEUMATOID-ARTHRITIS CLINICAL-TRIALS
    FELSON, DT
    ANDERSON, JJ
    BOERS, M
    BOMBARDIER, C
    CHERNOFF, M
    FRIED, B
    FURST, D
    GOLDSMITH, C
    KIESZAK, S
    LIGHTFOOT, R
    PAULUS, H
    TUGWELL, P
    WEINBLATT, M
    WIDMARK, R
    WILLIAMS, HJ
    WOLFE, F
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (06): : 729 - 740
  • [2] American College of Rheumatology/EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision
    Studenic, Paul
    Aletaha, Daniel
    de Wit, Maarten
    Stamm, Tanja A.
    Alasti, Farideh
    Lacaille, Diane
    Smolen, Josef S.
    Felson, David T.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 (01) : 15 - 22
  • [3] Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?
    Studenic, Paul
    Felson, David
    de Wit, Maarten
    Alasti, Farideh
    Stamm, Tanja A.
    Smolen, Josef S.
    Aletaha, Daniel
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (04) : 445 - 452